Literature DB >> 16625125

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Anand Kumar1, Daniel Roberts, Kenneth E Wood, Bruce Light, Joseph E Parrillo, Satendra Sharma, Robert Suppes, Daniel Feinstein, Sergio Zanotti, Leo Taiberg, David Gurka, Aseem Kumar, Mary Cheang.   

Abstract

OBJECTIVE: To determine the prevalence and impact on mortality of delays in initiation of effective antimicrobial therapy from initial onset of recurrent/persistent hypotension of septic shock.
DESIGN: A retrospective cohort study performed between July 1989 and June 2004.
SETTING: Fourteen intensive care units (four medical, four surgical, six mixed medical/surgical) and ten hospitals (four academic, six community) in Canada and the United States. PATIENTS: Medical records of 2,731 adult patients with septic shock.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The main outcome measure was survival to hospital discharge. Among the 2,154 septic shock patients (78.9% total) who received effective antimicrobial therapy only after the onset of recurrent or persistent hypotension, a strong relationship between the delay in effective antimicrobial initiation and in-hospital mortality was noted (adjusted odds ratio 1.119 [per hour delay], 95% confidence interval 1.103-1.136, p<.0001). Administration of an antimicrobial effective for isolated or suspected pathogens within the first hour of documented hypotension was associated with a survival rate of 79.9%. Each hour of delay in antimicrobial administration over the ensuing 6 hrs was associated with an average decrease in survival of 7.6%. By the second hour after onset of persistent/recurrent hypotension, in-hospital mortality rate was significantly increased relative to receiving therapy within the first hour (odds ratio 1.67; 95% confidence interval, 1.12-2.48). In multivariate analysis (including Acute Physiology and Chronic Health Evaluation II score and therapeutic variables), time to initiation of effective antimicrobial therapy was the single strongest predictor of outcome. Median time to effective antimicrobial therapy was 6 hrs (25-75th percentile, 2.0-15.0 hrs).
CONCLUSIONS: Effective antimicrobial administration within the first hour of documented hypotension was associated with increased survival to hospital discharge in adult patients with septic shock. Despite a progressive increase in mortality rate with increasing delays, only 50% of septic shock patients received effective antimicrobial therapy within 6 hrs of documented hypotension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16625125     DOI: 10.1097/01.CCM.0000217961.75225.E9

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  1440 in total

1.  Monomer complexes of polyadenylic acid.

Authors:  R Jeremy; H Davies
Journal:  Biochem Soc Trans       Date:  1975       Impact factor: 5.407

2.  Impact of Electronic Physician Order-Set on Antibiotic Ordering Time in Septic Patients in the Emergency Department.

Authors:  Emily L Fargo; Frank D'Amico; Aaron Pickering; Kathleen Fowler; Ronald Campbell; Megan Baumgartner
Journal:  Appl Clin Inform       Date:  2018-12-05       Impact factor: 2.342

3.  Emerging antimicrobial resistance among Escherichia coli strains in bloodstream infections in Toronto, 2006-2016: a retrospective cohort study.

Authors:  Sophie Mineau; Robert Kozak; Melissa Kissoon; Aimee Paterson; Anthony Oppedisano; Firas Douri; Kate Gogan; Barbara M Willey; Allison McGeer; Susan M Poutanen
Journal:  CMAJ Open       Date:  2018-12-03

4.  Comparison of the MALDI Biotyper system using Sepsityper specimen processing to routine microbiological methods for identification of bacteria from positive blood culture bottles.

Authors:  Blake W Buchan; Katherine M Riebe; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

5.  Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets.

Authors:  Kashyap Patel; Jason A Roberts; Jeffrey Lipman; Susan E Tett; Megan E Deldot; Carl M Kirkpatrick
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

6.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  How Can We Optimize Antibiotic Use in the PICU?

Authors:  Kathleen Chiotos; Jeffrey S Gerber; Adam S Himebauch
Journal:  Pediatr Crit Care Med       Date:  2017-09       Impact factor: 3.624

8.  Dosing of Appropriate Antibiotics and Time to Administration of First Doses in the Pediatric Emergency Department.

Authors:  Abby M Bailey; Maria Stephan; Kyle A Weant; Stephanie Baker Justice
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jul-Aug

Review 9.  Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors:  J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

10.  Use of Individual Pharmacokinetics to Improve Time to Therapeutic Vancomycin Trough in Pediatric Oncology Patients.

Authors:  Calvin L Miller; S Alexander Winans; John J Veillette; Steven C Forland
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.